DM
VIVO

Deerfield Management’s Meridian Bioscience Inc VIVO Stock Holding History

Deerfield Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,125,083
Closed -$23M – 138
2021
Q4 		$23M Sell
1,125,083
-938,000
-45% -$18M 0.48% 49
2021
Q3 		$39.7M Buy
2,063,083
+638,809
+45% +$12.7M 0.77% 39
2021
Q2 		$31.6M Buy
1,424,274
+535,005
+60% +$11.3M 0.56% 57
2021
Q1 		$23.3M Sell
889,269
-1,271,731
-59% -$30.2M 0.49% 70
2020
Q4 		$40.4M Buy
2,161,000
+652,602
+43% +$12.2M 0.8% 38
2020
Q3 		$25.6M Sell
1,508,398
-154,602
-9% -$3M 0.62% 55
2020
Q2 		$38.7M Buy
+1,663,000
New +$24.1M 1.13% 30

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deerfield Management's VIVO Position: Q1 2022 in Review

Deerfield Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 1,125,083 shares — an estimated $23M sold.

Deerfield Management first reported a position in VIVO in Q2 2020 and held it in 7 quarters. The position peaked at $40.4M in Q4 2020. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Deerfield Management reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
  • Deerfield Management sold 1,125,083 Meridian Bioscience Inc shares in Q1 2022, an estimated $23M.
  • Deerfield Management first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 7 quarters.
  • Deerfield Management's Meridian Bioscience Inc position peaked at $40.4M in Q4 2020.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Deerfield Management's 13F filing for Q1 2022, filed 16 May 2022.